News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
115,604 Results
Type
Article (12597)
Company Profile (60)
Press Release (102947)
Multimedia
Podcasts (7)
Webinars (2)
Section
Business (30431)
Career Advice (645)
Deals (5011)
Drug Delivery (30)
Drug Development (16659)
Employer Resources (44)
FDA (2531)
Job Trends (3325)
News (54226)
Policy (4838)
Tag
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (2)
2024 Biotech Bay Standard (6)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (1)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (1)
Academia (802)
Accelerated approval (2)
Adcomms (6)
Allergies (24)
Alliances (9585)
ALS (24)
Alzheimer's disease (323)
Antibody-drug conjugate (ADC) (19)
Approvals (2539)
Artificial intelligence (62)
Autoimmune disease (4)
Automation (2)
Bankruptcy (25)
Best Places to Work (3065)
BIOSECURE Act (4)
Biosimilars (14)
Biotechnology (52)
Bladder cancer (18)
Brain cancer (9)
Breast cancer (53)
Cancer (509)
Cardiovascular disease (49)
Career advice (547)
Career pathing (13)
CAR-T (43)
Cell therapy (136)
Cervical cancer (1)
Clinical research (12971)
Collaboration (234)
Compensation (80)
Complete response letters (4)
COVID-19 (541)
CRISPR (26)
C-suite (44)
Cystic fibrosis (61)
Data (594)
Decentralized trials (1)
Denatured (2)
Depression (8)
Diabetes (50)
Diagnostics (1739)
Digital health (2)
Diversity (3)
Diversity, equity & inclusion (16)
Drug discovery (39)
Drug pricing (22)
Drug shortages (5)
Duchenne muscular dystrophy (50)
Earnings (9985)
Editorial (17)
Employer branding (8)
Employer resources (44)
Events (16014)
Executive appointments (106)
FDA (2833)
Featured Employer (18)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (155)
Gene editing (71)
Generative AI (6)
Gene therapy (172)
GLP-1 (124)
Government (715)
Grass and pollen (1)
Guidances (10)
Healthcare (3415)
Huntington's disease (9)
IgA nephropathy (4)
Immunology and inflammation (24)
Indications (12)
Infectious disease (576)
Inflammatory bowel disease (26)
Inflation Reduction Act (8)
Influenza (12)
Intellectual property (20)
Interviews (126)
IPO (2446)
IRA (10)
Job creations (448)
Job search strategy (463)
Kidney cancer (3)
Labor market (23)
Layoffs (83)
Leadership (8)
Legal (777)
Liver cancer (19)
Lung cancer (65)
Lymphoma (43)
Management (14)
Manufacturing (66)
MASH (7)
Medical device (934)
Medtech (934)
Mergers & acquisitions (2686)
Metabolic disorders (139)
Multiple sclerosis (16)
NASH (1)
Neurodegenerative disease (24)
Neuropsychiatric disorders (4)
Neuroscience (471)
NextGen: Class of 2025 (1104)
Non-profit (979)
Northern California (586)
Now hiring (13)
Obesity (85)
Opinion (76)
Ovarian cancer (8)
Pain (14)
Pancreatic cancer (22)
Parkinson's disease (43)
Partnered (12)
Patents (34)
Patient recruitment (17)
Peanut (9)
People (9249)
Pharmaceutical (7)
Pharmacy benefit managers (2)
Phase I (4601)
Phase II (5814)
Phase III (4375)
Pipeline (253)
Policy (34)
Postmarket research (331)
Preclinical (2036)
Press Release (18)
Prostate cancer (30)
Psychedelics (7)
Radiopharmaceuticals (36)
Rare diseases (201)
Real estate (722)
Recruiting (16)
Regulatory (3842)
Reports (24)
Research institute (865)
Resumes & cover letters (84)
Rett syndrome (4)
RNA editing (4)
RSV (9)
Schizophrenia (17)
Series A (33)
Series B (14)
Service/supplier (2)
Sickle cell disease (20)
Southern California (446)
Special edition (15)
Spinal muscular atrophy (132)
Sponsored (7)
Startups (764)
Supply chain (12)
Tariffs (10)
The Weekly (5)
United States (4662)
Vaccines (126)
Venture capitalists (9)
Weight loss (38)
Women's health (3)
Worklife (6)
Date
Today (73)
Last 7 days (178)
Last 30 days (547)
Last 365 days (7382)
2025 (2269)
2024 (7708)
2023 (7966)
2022 (11766)
2021 (12096)
2020 (10060)
2019 (8482)
2018 (6189)
2017 (6106)
2016 (5547)
2015 (6217)
2014 (4389)
2013 (3560)
2012 (3444)
2011 (3376)
2010 (2903)
Location
Africa (198)
Alabama (3)
Alaska (2)
Arizona (23)
Arkansas (3)
Asia (6366)
Australia (1273)
California (1253)
Canada (278)
China (109)
Colorado (39)
Connecticut (67)
Delaware (22)
Europe (18598)
Florida (167)
Georgia (17)
Idaho (9)
Illinois (96)
India (2)
Indiana (97)
Iowa (2)
Japan (48)
Kansas (8)
Kentucky (5)
Louisiana (2)
Maine (2)
Maryland (181)
Massachusetts (1125)
Michigan (55)
Minnesota (28)
Missouri (4)
Montana (5)
Nebraska (5)
Nevada (12)
New Hampshire (3)
New Jersey (285)
New Mexico (4)
New York (333)
North Carolina (205)
North Dakota (5)
Northern California (586)
Ohio (42)
Oklahoma (1)
Oregon (7)
Pennsylvania (321)
Rhode Island (9)
South America (242)
South Carolina (1)
Southern California (446)
Tennessee (7)
Texas (132)
Utah (72)
Virginia (34)
Washington D.C. (15)
Washington State (127)
West Virginia (1)
Wisconsin (12)
115,604 Results for "ares genetics gmbh".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Approvals
ARS Wins FDA Approval for Neffy Spray for Children in Anaphylaxis
Neffy 1 mg is the “first significant innovation” for epinephrine delivery in small children aged 4 years and up in over 35 years, according to ARS Pharmaceuticals.
March 6, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Sirona Biochem Secures Strategic Investment Agreements and New Joint Venture with Promura GmbH
April 22, 2025
·
6 min read
Press Releases
Zymo Research Responds to Recent Court Ruling in Litigation with QIAGEN GmbH
March 19, 2025
·
1 min read
Press Releases
T-CURX GmbH Enters into Technology Access Agreement with Kytopen
February 14, 2025
·
5 min read
Business
OpGen Subsidiary Ares Genetics GmbH Enters into Collaboration Agreement with the Belgian National Reference Centre for Invasive S. pneumoniae at UZ Leuven
OpGen, Inc. announced today that its subsidiary Ares Genetics GmbH (Ares Genetics) and the Belgian National Reference Centre have entered into a collaboration agreement to jointly evaluate computational tools developed by Ares Genetics for the identification and characterization of Streptococcus pneumoniae for diagnostic purposes.
July 26, 2022
·
6 min read
Press Releases
Gift of Life Biologics and Cellex Cell Professionals GmbH Celebrate Successful Partnership to Deliver High-Quality Starting Materials for Final Drug Product Manufacturing in Cell and Gene Therapy
April 8, 2025
·
4 min read
Press Releases
JenaValve Announces Late-Breaking Data from the ALIGN-AR Pivotal Trial
April 1, 2025
·
3 min read
Press Releases
Swarm Oncology Ltd. and Cellex Cell Professionals GmbH Announce Strategic Partnership to Advance Swarm’s Innovative T Cell Therapies for Solid Cancers
February 25, 2025
·
3 min read
Deals
Great Point Partners Acquires Lyocontract GmbH, Germany-Based Drug Product CDMO
Great Point Partners, a Greenwich-based investment firm focused exclusively on the health care industry, announced the acquisition of Lyocontract GmbH, a premium independent drug product contract development and manufacturing organization based in Ilsenburg, Germany.
June 13, 2024
·
3 min read
Business
Oakwood Chemical Announces Strategic Partnership with EMP Biotech GmbH
Oakwood Chemical is thrilled to unveil its collaboration with EMP Biotech GmbH, a move set to streamline the oligo synthesis supply chain.
April 9, 2024
·
2 min read
1 of 11,561
Next
